BOOSTER RESPONSE TO RECOMBINANT YEAST-DERIVED HEPATITIS-B VACCINE IN VACCINEES WHOSE ANTI-HBS RESPONSES WERE INITIALLY ELICITED BY A PLASMA-DERIVED VACCINE

被引：8
|
作者：
CHAN, CY [1 ]
LEE, SD [1 ]
TSAI, YT [1 ]
LO, KJ [1 ]
机构：
[1] VET GEN HOSP,DEPT MED,DIV GASTROENTEROL,TAIPEI 11217,TAIWAN
来源：
VACCINE | 1991年 / 9卷 / 10期
关键词：
BOOSTER RESPONSE; PLASMA-DERIVED HEPATITIS-B VACCINE; RECOMBINANT YEAST-DERIVED VACCINE;
D O I：
10.1016/0264-410X(91)90294-G
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
One hundred and eight primary school students who had been vaccinated with three doses of a plasma-derived hepatitis B vaccine were randomly divided into two groups, to receive a booster dose of either the same vaccine or of a recombinant yeast-derived vaccine. The pre-booster anti-hepatitis B surface antigen (HBs) geometric mean titres (GMT) were similar in both groups (281.8 mIU ml-1 versus 295.1 mIU ml-1, p > 0.5). One month after booster vaccination, all the vaccinees in both groups had a marked elevation in their anti-HBs titres, the anti-HBs GMT in group 1 and group 2 being 19 952.6 and 51 286.1 mIU ml-1 (p < 0.05), respectively. In conclusion, the recombinant yeast-derived hepatitis B vaccine was able to elicit an excellent booster response in vaccinees who had originally received a plasma-derived vaccine.
引用
收藏
页码：765 / 767
页数：3
相关论文
共 50 条
  • [21] PERSISTENCE OF ANTIBODIES FOLLOWING VACCINATION WITH A YEAST-DERIVED RECOMBINANT HEPATITIS-B VACCINE
    JUST, M
    BERGER, R
    SCHEIERMANN, N
    VACCINE, 1988, 6 (05) : 401 - 402
  • [22] EFFECTS OF A RECOMBINANT YEAST-DERIVED HEPATITIS-B VACCINE IN HEALTHY-ADULTS
    SCHEIERMANN, N
    GESEMANN, KM
    KREUZFELDER, E
    PAAR, D
    POSTGRADUATE MEDICAL JOURNAL, 1987, 63 : 115 - 119
  • [23] ANTI-HBS RESPONSES TO VACCINATION WITH A HUMAN HEPATITIS-B VACCINE MADE BY RECOMBINANT-DNA TECHNOLOGY IN YEAST
    HOLLINGER, FB
    TROISI, CL
    PEPE, PE
    JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (01): : 156 - 159
  • [24] CLINICAL-EVALUATION OF LOW-DOSE INTRADERMALLY ADMINISTERED HEPATITIS-B VACCINE - A COMPARISON OF PLASMA-DERIVED AND RECOMBINANT YEAST-DERIVED VACCINES
    SOYLETIR, G
    BAHCECI, E
    AKOGLU, E
    SOYOGUL, U
    LAWRANCE, RA
    VACCINE, 1992, 10 (05) : 301 - 304
  • [25] IMMUNOGENICITY OF A RECOMBINANT YEAST-DERIVED HEPATITIS-B VACCINE (ENGERIX-B) IN CHILDREN
    MOYES, C
    MILNE, A
    NEW ZEALAND MEDICAL JOURNAL, 1988, 101 (843) : 162 - 164
  • [26] KINETICS OF ANTI-HBS AFTER HEPATITIS-B VACCINATION - A COMPARISON OF 2 RECOMBINANT AND ONE PLASMA-DERIVED VACCINES
    GESEMANN, M
    SCHRODER, S
    SCHEIERMANN, N
    MAURER, C
    ARCHIVES OF VIROLOGY, 1992, : 154 - 155
  • [27] CLINICAL-EXPERIENCE WITH A YEAST-DERIVED HEPATITIS-B VACCINE
    ANDRE, FE
    SAFARY, A
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A99 - A99
  • [28] IMMUNOGENICITY OF A RECOMBINANT PRE-S2-CONTAINING HEPATITIS-B VACCINE VERSUS PLASMA-DERIVED VACCINE ADMINISTERED AS A BOOSTER
    BUCHER, B
    FRANCIOLI, P
    GEUDELIN, B
    FRITZELL, B
    LAVANCHY, D
    FREI, PC
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (03) : 212 - 217
  • [29] IMMUNE-RESPONSE AFTER VACCINATION WITH RECOMBINANT HEPATITIS-B VACCINE AS COMPARED TO THAT AFTER PLASMA-DERIVED VACCINE
    HEIJTINK, RA
    KRUINING, J
    BAKKER, M
    SCHALM, SW
    ANTIVIRAL RESEARCH, 1985, : 273 - 279
  • [30] IMMUNOGENICITY AND SAFETY OF LOW-DOSES OF RECOMBINANT YEAST-DERIVED HEPATITIS-B VACCINE
    TAN, KL
    OON, CJ
    GOH, KT
    WONG, LYM
    CHAN, SH
    ACTA PAEDIATRICA SCANDINAVICA, 1990, 79 (6-7): : 593 - 598
12345